 |
 |
Schwarz Pharma gets FDA OK on Parcopa (DE:722190) By Emily Church 2:44am 08/30/04 LONDON (CBS.MW) -- German drugmaker Schwarz Pharma AG (DE:722190) Monday announced the U.S. Food and Drug Administration granted approval to market Parcopa, the orally disintegrating tablets for patients suffering from Parkinson's disease. "Parcopa will establish our presence in the neurology offices and help prepare the launch platform for our future products for Parkinson's disease and other neurological disorders," the drugmaker said. SOURCE: CBS MarketWatch http://tinyurl.com/6onc3 Reference: PARCOPA™ (carbidopa-levodopa orally disintegrating tablets) 10 mg/100 mg • 25 mg/100 mg • 25 mg/250 mg https://www.parcopa.com/index.html https://www.parcopa.com/PARCOPAFullPI.PDF RapiTab Technology With RapiTab Technology, the drugs you know and trust dissolve on the tongue for easy oral delivery... http://www.rapitabtech.com/ Clinical Trial Parkinson's Disease. Drug under Investigation: PARCOPA (Carbidopa/Levodopa) http://www.clinicaltrialsinc.com/parcopa.html * * * ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn